Stock futures trade mixed after Trump announces 3-week extension to Israel-Lebanon ceasefire: Live updates
On Thursday, the Nasdaq Composite suffered its worst daily performance in nearly a month.
Cohere to acquire German AI company Aleph Alpha as it looks to expand in Europe
Schwarz Group — a key backer of Aleph Alpha — plans to invest $600 million in Cohere’s upcoming Series E round as part of the deal.
Pentagon email floats suspending Spain from NATO, other steps over Iran rift, Reuters reports
An internal Pentagon email outlines options for the U.S. to punish NATO allies it believes failed to support its efforts in Iran, a U.S. official told Reuters.
TSMC shares jump to record high as Taiwan eases single-stock investment caps for funds
TSMC, whose shares had a hit a record high on Thursday as well, last week reported a 58% increase in first-quarter profit.
China’s DeepSeek releases preview of long-awaited V4 model as AI race intensifies
Chinese AI startup DeepSeek has released a preview version of its long awaited V4 large language model.
U.S. soldier arrested for $400K winning Polymarket bets on Maduro capture, DOJ says
The arrest comes as concerns have grown about people with inside information making bets on the Polymarket and Kalshi prediction markets.
Trump says Israel-Lebanon ceasefire extended by three weeks
Israel and Lebanon agreed to extend their ceasefire by three weeks following a meeting in the White House with top U.S. officials, President Donald Trump said.
NYC Mayor Mamdani knocked Ken Griffin in pied-a-terre tax promo. His firm calls the move ‘shameful’
Chief Operating Officer Gerald Beeson saying in a memo that targeting Griffin showed “ignorance and disdain” toward contributors to the city’s economy.
Nike cuts 1,400 roles in second round of layoffs this year
Nike announced 1,400 layoffs, primarily in its technology department, on Thursday after cutting 775 jobs in January.
Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free
Regeneron is the latest in a string of major drugmakers to make pricing concessions for new and existing medicines under agreements with Trump.